Targeting SHP2 and RAS MAPK pathway in neuroblastoma

Valencia-Sama, I; Adderley, T; Kee, L; Christopher, G; Kano, Y; Ohh, M; Irwin, M

CANCER RESEARCH, 2019; 79 (13):